NCT05525858 2025-04-27
KOSMOSII
Seoul National University Bundang Hospital
Recruiting
Clinical Trials
17 trialsNCT05834348 2025-03-30
DELINOR
Pfizer
Completed
NCT03192501 2024-06-25
iCAGES-guided Precision Therapy for Cancers in Contrast to Standard Care or IHC-guided Theray
Second Affiliated Hospital of Guangzhou Medical University
Recruiting
NCT03647592 2023-12-27
Real World Study on Erlotinib/Gefitinib Combined With Bevacizumab in Advanced Non-aquamous Non-small Cell Lung Cancer
Hunan Province Tumor Hospital
Unknown
NCT02154490 2023-06-01
Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer
SWOG Cancer Research Network
Completed
NCT04179890 2023-05-25
UpSwinG
Boehringer Ingelheim
Completed
NCT04575415 2020-10-20
BELLA
Guangdong Association of Clinical Trials
Unknown
NCT04115410 2020-05-28
PD-1 Immune Checkpoint Inhibitors and Immune-Related Adverse Events: a Cohort Study
Sungkyunkwan University
Unknown
NCT02745691 2019-12-13
Psychometric Properties of the EORTC QLQ-LC29
University Hospital Regensburg
Completed
NCT01782690 2018-07-23
An Observational Study of Erlotinib Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer
Hoffmann-La Roche
Completed
NCT01836133 2017-05-04
ELEMENT
Hoffmann-La Roche
Completed
NCT01990261 2016-09-16
STAR
Hoffmann-La Roche
Terminated
NCT01161173 2016-03-28
TEAM
Hoffmann-La Roche
Completed
NCT02595450 2016-01-25
A Non-interventional Trial of Erlotinib (Tarceva) Metastatic Non-small Cell Lung Cancer
Hoffmann-La Roche
Completed
NCT01664533 2015-12-28
TIME
Hoffmann-La Roche
Completed
NCT00418704 2013-10-01
Elderly Independent Patients With Non Small Cell Lung Cancer (NSCLC)
Groupe Francais De Pneumo-Cancerologie
Completed
NCT00419042 2013-10-01
Elderly Dependent Patients With Non Small Cell Lung Cancer (NSCLC)
Groupe Francais De Pneumo-Cancerologie
Completed